HEADER    IMMUNE SYSTEM                           17-OCT-03   1R70              
TITLE     MODEL OF HUMAN IGA2 DETERMINED BY SOLUTION SCATTERING, CURVE          
TITLE    2 FITTING AND HOMOLOGY MODELLING                                       
COMPND    MOL_ID: 1;                                                            
COMPND   2 MOLECULE: HUMAN IGA2(M1) LIGHT CHAIN;                                
COMPND   3 CHAIN: A, C;                                                         
COMPND   4 ENGINEERED: YES;                                                     
COMPND   5 MOL_ID: 2;                                                           
COMPND   6 MOLECULE: HUMAN IGA2(M1) HEAVY CHAIN;                                
COMPND   7 CHAIN: B, D;                                                         
COMPND   8 ENGINEERED: YES                                                      
SOURCE    MOL_ID: 1;                                                            
SOURCE   2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;                                   
SOURCE   3 ORGANISM_COMMON: HUMAN;                                              
SOURCE   4 ORGANISM_TAXID: 9606;                                                
SOURCE   5 GENE: HUMAN ALPHA 2 GENE (LIGHT CHAIN);                              
SOURCE   6 EXPRESSION_SYSTEM: CRICETULUS GRISEUS;                               
SOURCE   7 EXPRESSION_SYSTEM_COMMON: CHINESE HAMSTER;                           
SOURCE   8 EXPRESSION_SYSTEM_TAXID: 10029;                                      
SOURCE   9 EXPRESSION_SYSTEM_STRAIN: K1;                                        
SOURCE  10 EXPRESSION_SYSTEM_CELL_LINE: CHINESE HAMSTER OVARY (CHO);            
SOURCE  11 EXPRESSION_SYSTEM_ORGAN: OVARY;                                      
SOURCE  12 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID;                              
SOURCE  13 EXPRESSION_SYSTEM_PLASMID: PEE6.HCMV;                                
SOURCE  14 MOL_ID: 2;                                                           
SOURCE  15 ORGANISM_SCIENTIFIC: HOMO SAPIENS;                                   
SOURCE  16 ORGANISM_COMMON: HUMAN;                                              
SOURCE  17 ORGANISM_TAXID: 9606;                                                
SOURCE  18 GENE: HUMAN ALPHA 2 GENE (HEAVY CHAIN);                              
SOURCE  19 EXPRESSION_SYSTEM: CRICETULUS GRISEUS;                               
SOURCE  20 EXPRESSION_SYSTEM_COMMON: CHINESE HAMSTER;                           
SOURCE  21 EXPRESSION_SYSTEM_TAXID: 10029;                                      
SOURCE  22 EXPRESSION_SYSTEM_STRAIN: K1;                                        
SOURCE  23 EXPRESSION_SYSTEM_CELL_LINE: CHINESE HAMSTER OVARY (CHO);            
SOURCE  24 EXPRESSION_SYSTEM_ORGAN: OVARY;                                      
SOURCE  25 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID;                              
SOURCE  26 EXPRESSION_SYSTEM_PLASMID: PEE6.HCMV                                 
KEYWDS    IMMUNOLOGY, ANTIBODY, IGA, GLYCOPROTEIN, IG FOLD, IMMUNE              
KEYWDS   2 SYSTEM                                                               
EXPDTA    SOLUTION SCATTERING                                                   
MDLTYP    CA ATOMS ONLY, CHAIN A, B, C, D                                       
AUTHOR    P.B.FURTADO,P.W.WHITTY,A.ROBERTSON,J.T.EATON,A.ALMOGREN,              
AUTHOR   2 M.A.KERR,J.M.WOOF,S.J.PERKINS                                        
REVDAT   3   07-APR-10 1R70    1       REMARK                                   
REVDAT   2   24-FEB-09 1R70    1       VERSN                                    
REVDAT   1   19-OCT-04 1R70    0                                                
JRNL        AUTH   P.B.FURTADO,P.W.WHITTY,A.ROBERTSON,J.T.EATON,                
JRNL        AUTH 2 A.ALMOGREN,M.A.KERR,J.M.WOOF,S.J.PERKINS                     
JRNL        TITL   SOLUTION STRUCTURE DETERMINATION OF MONOMERIC HUMAN          
JRNL        TITL 2 IGA2 BY X-RAY AND NEUTRON SCATTERING, ANALYTICAL             
JRNL        TITL 3 ULTRACENTRIFUGATION AND CONSTRAINED MODELLING: A             
JRNL        TITL 4 COMPARISON WITH MONOMERIC HUMAN IGA1.                        
JRNL        REF    J.MOL.BIOL.                   V. 338   921 2004              
JRNL        REFN                   ISSN 0022-2836                               
JRNL        PMID   15111057                                                     
JRNL        DOI    10.1016/J.JMB.2004.03.007                                    
REMARK   2                                                                      
REMARK   2 RESOLUTION. NOT APPLICABLE.                                          
REMARK   3                                                                      
REMARK   3 REFINEMENT.                                                          
REMARK   3   PROGRAM     : INSIGHTII (DISCOVER)                                 
REMARK   3   AUTHORS     :                                                      
REMARK   3                                                                      
REMARK   3  NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.                    
REMARK   3   PROTEIN ATOMS            : 1352                                    
REMARK   3   NUCLEIC ACID ATOMS       : 0                                       
REMARK   3   HETEROGEN ATOMS          : 0                                       
REMARK   3   SOLVENT ATOMS            : 0                                       
REMARK   3                                                                      
REMARK   3  OTHER REFINEMENT REMARKS: NULL                                      
REMARK   4                                                                      
REMARK   4 1R70 COMPLIES WITH FORMAT V. 3.15, 01-DEC-08                         
REMARK 100                                                                      
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 01-DEC-03.                  
REMARK 100 THE RCSB ID CODE IS RCSB020514.                                      
REMARK 265                                                                      
REMARK 265 EXPERIMENTAL DETAILS                                                 
REMARK 265                                                                      
REMARK 265 EXPERIMENT TYPE : SMALL ANGLE X-RAY SCATTERING                       
REMARK 265  DATA ACQUISITION                                                    
REMARK 265   RADIATION/NEUTRON SOURCE                 : SRS BEAMLINE 2.1        
REMARK 265   SYNCHROTRON (Y/N)                        : Y                       
REMARK 265   BEAMLINE TYPE                            : 2.1                     
REMARK 265   BEAMLINE INSTRUMENT                      : NULL                    
REMARK 265   DETECTOR TYPE                            : 500-CHANNEL             
REMARK 265                                              QUADRANT                
REMARK 265   DETECTOR MANUFACTURER DETAILS            : NULL                    
REMARK 265   TEMPERATURE (KELVIN)                     : 288                     
REMARK 265   PH                                       : 7.4                     
REMARK 265   NUMBER OF TIME FRAMES USED               : 10                      
REMARK 265   PROTEIN CONCENTRATION RANGE (MG/ML)      : 2-15                    
REMARK 265   SAMPLE BUFFER                            : DULBECCO PBS            
REMARK 265   DATA REDUCTION SOFTWARE                  : OTOKO                   
REMARK 265   GUINIER MEAN RADIUS OF GYRATION (NM)     : 5.17                    
REMARK 265   SIGMA MEAN RADIUS OF GYRATION            : 0.11                    
REMARK 265   R(XS-1) MEAN CROSS SECTIONAL RADII (NM)  : 2.39                    
REMARK 265   R(XS-1) SIGMA MEAN CROSS SECTIONAL RADII : 0.10                    
REMARK 265   R(XS-2) MEAN CROSS SECTIONAL RADII (NM)  : 1.37                    
REMARK 265   R(XS-2) SIGMA MEAN CROSS SECTIONAL RADII : 0.16                    
REMARK 265   P(R) PROTEIN LENGTH (NM)                 : 1                       
REMARK 265                                                                      
REMARK 265 EXPERIMENT TYPE : SMALL ANGLE X-RAY SCATTERING                       
REMARK 265  DATA ACQUISITION                                                    
REMARK 265   RADIATION/NEUTRON SOURCE                 : ESRF BEAMLINE ID02      
REMARK 265   SYNCHROTRON (Y/N)                        : Y                       
REMARK 265   BEAMLINE TYPE                            : ID02                    
REMARK 265   BEAMLINE INSTRUMENT                      : NULL                    
REMARK 265   DETECTOR TYPE                            : FRELON CCD CAMERA       
REMARK 265   DETECTOR MANUFACTURER DETAILS            : NULL                    
REMARK 265   TEMPERATURE (KELVIN)                     : 288                     
REMARK 265   PH                                       : 7.4                     
REMARK 265   NUMBER OF TIME FRAMES USED               : 10                      
REMARK 265   PROTEIN CONCENTRATION RANGE (MG/ML)      : 0.55-1.12               
REMARK 265   SAMPLE BUFFER                            : DULBECCO PBS            
REMARK 265   DATA REDUCTION SOFTWARE                  : MULTICCD                
REMARK 265   GUINIER MEAN RADIUS OF GYRATION (NM)     : 5.18                    
REMARK 265   SIGMA MEAN RADIUS OF GYRATION            : 0.09                    
REMARK 265   R(XS-1) MEAN CROSS SECTIONAL RADII (NM)  : 2.47                    
REMARK 265   R(XS-1) SIGMA MEAN CROSS SECTIONAL RADII : 0.09                    
REMARK 265   R(XS-2) MEAN CROSS SECTIONAL RADII (NM)  : 1.47                    
REMARK 265   R(XS-2) SIGMA MEAN CROSS SECTIONAL RADII : 0.08                    
REMARK 265   P(R) PROTEIN LENGTH (NM)                 : 16                      
REMARK 265                                                                      
REMARK 265 EXPERIMENT TYPE : SMALL ANGLE NEUTRON SCATTERING                     
REMARK 265  DATA ACQUISITION                                                    
REMARK 265   RADIATION/NEUTRON SOURCE                 : ISIS                    
REMARK 265   SYNCHROTRON (Y/N)                        : N                       
REMARK 265   BEAMLINE TYPE                            : PULSED NEUTRON          
REMARK 265   BEAMLINE INSTRUMENT                      : LOQ                     
REMARK 265   DETECTOR TYPE                            : AREA (TIME-OF-          
REMARK 265                                              FLIGHT)                 
REMARK 265   DETECTOR MANUFACTURER DETAILS            : NULL                    
REMARK 265   TEMPERATURE (KELVIN)                     : 288                     
REMARK 265   PH                                       : 7.4                     
REMARK 265   NUMBER OF TIME FRAMES USED               : NULL                    
REMARK 265   PROTEIN CONCENTRATION RANGE (MG/ML)      : 2.0-3.0                 
REMARK 265   SAMPLE BUFFER                            : PBS IN 99.9% D2O        
REMARK 265   DATA REDUCTION SOFTWARE                  : COLLETTE                
REMARK 265   GUINIER MEAN RADIUS OF GYRATION (NM)     : 5.03                    
REMARK 265   SIGMA MEAN RADIUS OF GYRATION            : 0.01                    
REMARK 265   R(XS-1) MEAN CROSS SECTIONAL RADII (NM)  : 2.21                    
REMARK 265   R(XS-1) SIGMA MEAN CROSS SECTIONAL RADII : 0.10                    
REMARK 265   R(XS-2) MEAN CROSS SECTIONAL RADII (NM)  : 1.04                    
REMARK 265   R(XS-2) SIGMA MEAN CROSS SECTIONAL RADII : 0.06                    
REMARK 265   P(R) PROTEIN LENGTH (NM)                 : 1                       
REMARK 265                                                                      
REMARK 265 DATA ANALYSIS AND MODEL FITTING:                                     
REMARK 265  METHOD USED TO DETERMINE THE STRUCTURE: CONSTRAINED SCATTERING      
REMARK 265                                          FITTING OF HOMOLOGY         
REMARK 265                                          MODELS                      
REMARK 265  SOFTWARE USED    : INSIGHT II, HOMOLOGY, DISCOVERY,                 
REMARK 265                     BIOPOLYMER, DELPHI, O, SCTPL7, GNOM              
REMARK 265  SOFTWARE AUTHORS : ACCELRYS                                         
REMARK 265  STARTING MODEL   : NULL                                             
REMARK 265                                                                      
REMARK 265 CONFORMERS, NUMBER CALCULATED   : 10000                              
REMARK 265 CONFORMERS, NUMBER SUBMITTED    : 1                                  
REMARK 265 CONFORMERS, SELECTION CRITERIA  : THE MODELLED SCATTERING            
REMARK 265  CURVES WERE ASSESSED BY CALCULATION OF THE RG, RSX-1 AND            
REMARK 265  VALUES IN THE SAME Q RANGES USED IN THE EXPERIMENTAL GUINIER        
REMARK 265  FITS. MODELS WERE THEN RANKED USING A GOODNESS-OF-FIT R-FACTOR      
REMARK 265  DEFINED BY ANALOGY WITH PROTEIN CRYSTALLOGRAPHY AND BASED ON        
REMARK 265  THE EXPERIMENTAL CURVES IN THE Q RANGE EXTENDING TO 2.2 NM-1        
REMARK 265  (ESRF X-RAYS) AND 2.2 NM-1 (ISIS NEUTRONS).                         
REMARK 265                                                                      
REMARK 265 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1                   
REMARK 265                                                                      
REMARK 265  OTHER DETAILS: HOMOLOGY MODELS WERE BUILT FOR THE IGA2 FAB AND      
REMARK 265  FC FRAGMENTS STARTING FROM THE IGA1 MODEL (PDB ENTRY 1IGA).         
REMARK 265  THE POSITIONS OF THE FAB FRAGMENTS RELATIVE TO THE FC FRAGMENT      
REMARK 265  WERE DETERMINED BY AN APPROACH THAT COMBINED RANDOM HINGE           
REMARK 265  PEPTIDE STRUCTURES PRODUCED BY MOLECULAR DYNAMICS SIMULATIONS       
REMARK 265  WITH CURVE-FITTING TO EXPERIMENTAL SOLUTION SCATTERING DATA.        
REMARK 265  THE X-RAY AND NEUTRON SCATTERING CURVE I(Q) WAS CALCULATED          
REMARK 265  ASSUMING A UNIFORM SCATTERING DENSITY FOR THE SPHERES USING         
REMARK 265  THE DEBYE EQUATION AS ADAPTED TO SPHERES. X-RAY CURVES WERE         
REMARK 265  CALCULATED FROM THE HYDRATED SPHERE MODELS WITHOUT CORRECTIONS      
REMARK 265  FOR WAVELENGTH SPREAD OR BEAM DIVERGENCE, WHILE THESE               
REMARK 265  CORRECTIONS WERE APPLIED FOR THE NEUTRON CURVES BUT NOW USING       
REMARK 265  UNHYDRATED MODELS. A SINGLE ARRANGEMENT OF THE FAB FRAGMENTS        
REMARK 265  IS PRESENTED, WHICH IS REPRESENTATIVE OF A FAMILY OF                
REMARK 265  STRUCTURES THAT FIT THE SCATTERING DATA. MORE DETAILS ON THE        
REMARK 265  MODELLING STRATEGY ARE CONTAINED IN THE PRIMARY REFERENCE.          
REMARK 300                                                                      
REMARK 300 BIOMOLECULE: 1                                                       
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM                
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN                  
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON               
REMARK 300 BURIED SURFACE AREA.                                                 
REMARK 350                                                                      
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN           
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE                
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS          
REMARK 350 GIVEN BELOW.  BOTH NON-CRYSTALLOGRAPHIC AND                          
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.                               
REMARK 350                                                                      
REMARK 350 BIOMOLECULE: 1                                                       
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC                        
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D                            
REMARK 350   BIOMT1   1  1.000000  0.000000  0.000000        0.00000            
REMARK 350   BIOMT2   1  0.000000  1.000000  0.000000        0.00000            
REMARK 350   BIOMT3   1  0.000000  0.000000  1.000000        0.00000            
REMARK 900                                                                      
REMARK 900 RELATED ENTRIES                                                      
REMARK 900 RELATED ID: 1VGE   RELATED DB: PDB                                   
REMARK 900 HUMAN IGG1 TR1_9 FAB. USED AS TEMPLATE FOR VL, CL AND VH             
REMARK 900 DOMAINS                                                              
REMARK 900 RELATED ID: 2FBJ   RELATED DB: PDB                                   
REMARK 900 MOUSE IGA JS39 FAB. USED AS TEMPLATE FOR CH1 DOMAIN                  
REMARK 900 RELATED ID: 1FC1   RELATED DB: PDB                                   
REMARK 900 HUMAN IGG FC (CHAIN A). USED AS TEMPLATE FOR CH2 AND CH3             
REMARK 900 DOMAINS                                                              
REMARK 999                                                                      
REMARK 999 SEQUENCE                                                             
REMARK 999 AT THE TIME OF PROCESSING, THERE WERE NO                             
REMARK 999 SUITABLE SEQUENCE DATABASE REFERENCES FOR                            
REMARK 999 THE PROTEINS IN THIS ENTRY.                                          
DBREF  1R70 A    1   214  PDB    1R70     1R70             1    214             
DBREF  1R70 B  215   676  PDB    1R70     1R70           215    676             
DBREF  1R70 C  677   890  PDB    1R70     1R70           677    890             
DBREF  1R70 D  891  1352  PDB    1R70     1R70           891   1352             
SEQRES   1 A  214  GLU LEU VAL MET THR GLN SER PRO SER SER LEU SER ALA          
SEQRES   2 A  214  SER VAL GLY ASP ARG VAL ASN ILE ALA CYS ARG ALA SER          
SEQRES   3 A  214  GLN GLY ILE SER SER ALA LEU ALA TRP TYR GLN GLN LYS          
SEQRES   4 A  214  PRO GLY LYS ALA PRO ARG LEU LEU ILE TYR ASP ALA SER          
SEQRES   5 A  214  ASN LEU GLU SER GLY VAL PRO SER ARG PHE SER GLY SER          
SEQRES   6 A  214  GLY SER GLY THR ASP PHE THR LEU THR ILE SER SER LEU          
SEQRES   7 A  214  GLN PRO GLU ASP PHE ALA ILE TYR TYR CYS GLN GLN PHE          
SEQRES   8 A  214  ASN SER TYR PRO LEU THR PHE GLY GLY GLY THR LYS VAL          
SEQRES   9 A  214  GLU ILE LYS ARG THR VAL ALA ALA PRO SER VAL PHE ILE          
SEQRES  10 A  214  PHE PRO PRO SER ASP GLU GLN LEU LYS SER GLY THR ALA          
SEQRES  11 A  214  SER VAL VAL CYS LEU LEU ASN ASN PHE TYR PRO ARG GLU          
SEQRES  12 A  214  ALA LYS VAL GLN TRP LYS VAL ASP ASN ALA LEU GLN SER          
SEQRES  13 A  214  GLY ASN SER GLN GLU SER VAL THR GLU GLN ASP SER LYS          
SEQRES  14 A  214  ASP SER THR TYR SER LEU SER SER THR LEU THR LEU SER          
SEQRES  15 A  214  LYS ALA ASP TYR GLU LYS HIS LYS VAL TYR ALA CYS GLU          
SEQRES  16 A  214  VAL THR HIS GLN GLY LEU SER SER PRO VAL THR LYS SER          
SEQRES  17 A  214  PHE ASN ARG GLY GLU CYS                                      
SEQRES   1 B  462  GLN VAL LYS LEU LEU GLU GLN SER GLY ALA GLU VAL LYS          
SEQRES   2 B  462  LYS PRO GLY ALA SER VAL LYS VAL SER CYS LYS ALA SER          
SEQRES   3 B  462  GLY TYR SER PHE THR SER TYR GLY LEU HIS TRP VAL ARG          
SEQRES   4 B  462  GLN ALA PRO GLY GLN ARG LEU GLU TRP MET GLY TRP ILE          
SEQRES   5 B  462  SER ALA GLY THR GLY ASN THR LYS TYR SER GLN LYS PHE          
SEQRES   6 B  462  ARG GLY ARG VAL THR PHE THR ARG ASP THR SER ALA THR          
SEQRES   7 B  462  THR ALA TYR MET GLY LEU SER SER LEU ARG PRO GLU ASP          
SEQRES   8 B  462  THR ALA VAL TYR TYR CYS ALA ARG ASP PRO TYR GLY GLY          
SEQRES   9 B  462  GLY LYS SER GLU PHE ASP TYR TRP GLY GLN GLY THR LEU          
SEQRES  10 B  462  VAL THR VAL SER SER ALA SER PRO THR SER PRO LYS VAL          
SEQRES  11 B  462  PHE PRO LEU SER LEU ASP SER THR PRO GLN ASP GLY ASN          
SEQRES  12 B  462  VAL VAL VAL ALA CYS LEU VAL GLN GLY PHE PHE PRO GLN          
SEQRES  13 B  462  GLU PRO LEU SER VAL THR TRP SER GLU SER GLY GLN ASN          
SEQRES  14 B  462  VAL THR ALA ARG ASN PHE PRO PRO SER GLN ASP ALA SER          
SEQRES  15 B  462  GLY ASP LEU TYR THR THR SER SER GLN LEU THR LEU PRO          
SEQRES  16 B  462  ALA THR GLN CYS PRO ASP GLY LYS SER VAL THR CYS HIS          
SEQRES  17 B  462  VAL LYS HIS TYR THR ASN PRO SER GLN ASP VAL THR VAL          
SEQRES  18 B  462  PRO CYS PRO VAL PRO PRO PRO PRO PRO CYS CYS HIS PRO          
SEQRES  19 B  462  ARG LEU SER LEU HIS ARG PRO ALA LEU GLU ASP LEU LEU          
SEQRES  20 B  462  LEU GLY SER GLU ALA ASN LEU THR CYS THR LEU THR GLY          
SEQRES  21 B  462  LEU ARG ASP ALA SER GLY ALA THR PHE THR TRP THR PRO          
SEQRES  22 B  462  SER SER GLY LYS SER ALA VAL GLN GLY PRO PRO GLU ARG          
SEQRES  23 B  462  ASP LEU CYS GLY CYS TYR SER VAL SER SER VAL LEU PRO          
SEQRES  24 B  462  GLY CYS ALA GLN PRO TRP ASN HIS GLY GLU THR PHE THR          
SEQRES  25 B  462  CYS THR ALA ALA HIS PRO GLU LEU LYS THR PRO LEU THR          
SEQRES  26 B  462  ALA ASN ILE THR LYS SER GLY ASN THR PHE ARG PRO GLU          
SEQRES  27 B  462  VAL HIS LEU LEU PRO PRO PRO SER GLU GLU LEU ALA LEU          
SEQRES  28 B  462  ASN GLU LEU VAL THR LEU THR CYS LEU ALA ARG GLY PHE          
SEQRES  29 B  462  SER PRO LYS ASP VAL LEU VAL ARG TRP LEU GLN GLY SER          
SEQRES  30 B  462  GLN GLU LEU PRO ARG GLU LYS TYR LEU THR TRP ALA SER          
SEQRES  31 B  462  ARG GLN GLU PRO SER GLN GLY THR THR THR PHE ALA VAL          
SEQRES  32 B  462  THR SER ILE LEU ARG VAL ALA ALA GLU ASP TRP LYS LYS          
SEQRES  33 B  462  GLY ASP THR PHE SER CYS MET VAL GLY HIS GLU ALA LEU          
SEQRES  34 B  462  PRO LEU ALA PHE THR GLN LYS THR ILE ASP ARG LEU ALA          
SEQRES  35 B  462  GLY LYS PRO THR HIS VAL ASN VAL SER VAL VAL MET ALA          
SEQRES  36 B  462  GLU VAL ASP GLY THR CYS TYR                                  
SEQRES   1 C  214  GLU LEU VAL MET THR GLN SER PRO SER SER LEU SER ALA          
SEQRES   2 C  214  SER VAL GLY ASP ARG VAL ASN ILE ALA CYS ARG ALA SER          
SEQRES   3 C  214  GLN GLY ILE SER SER ALA LEU ALA TRP TYR GLN GLN LYS          
SEQRES   4 C  214  PRO GLY LYS ALA PRO ARG LEU LEU ILE TYR ASP ALA SER          
SEQRES   5 C  214  ASN LEU GLU SER GLY VAL PRO SER ARG PHE SER GLY SER          
SEQRES   6 C  214  GLY SER GLY THR ASP PHE THR LEU THR ILE SER SER LEU          
SEQRES   7 C  214  GLN PRO GLU ASP PHE ALA ILE TYR TYR CYS GLN GLN PHE          
SEQRES   8 C  214  ASN SER TYR PRO LEU THR PHE GLY GLY GLY THR LYS VAL          
SEQRES   9 C  214  GLU ILE LYS ARG THR VAL ALA ALA PRO SER VAL PHE ILE          
SEQRES  10 C  214  PHE PRO PRO SER ASP GLU GLN LEU LYS SER GLY THR ALA          
SEQRES  11 C  214  SER VAL VAL CYS LEU LEU ASN ASN PHE TYR PRO ARG GLU          
SEQRES  12 C  214  ALA LYS VAL GLN TRP LYS VAL ASP ASN ALA LEU GLN SER          
SEQRES  13 C  214  GLY ASN SER GLN GLU SER VAL THR GLU GLN ASP SER LYS          
SEQRES  14 C  214  ASP SER THR TYR SER LEU SER SER THR LEU THR LEU SER          
SEQRES  15 C  214  LYS ALA ASP TYR GLU LYS HIS LYS VAL TYR ALA CYS GLU          
SEQRES  16 C  214  VAL THR HIS GLN GLY LEU SER SER PRO VAL THR LYS SER          
SEQRES  17 C  214  PHE ASN ARG GLY GLU CYS                                      
SEQRES   1 D  462  GLN VAL LYS LEU LEU GLU GLN SER GLY ALA GLU VAL LYS          
SEQRES   2 D  462  LYS PRO GLY ALA SER VAL LYS VAL SER CYS LYS ALA SER          
SEQRES   3 D  462  GLY TYR SER PHE THR SER TYR GLY LEU HIS TRP VAL ARG          
SEQRES   4 D  462  GLN ALA PRO GLY GLN ARG LEU GLU TRP MET GLY TRP ILE          
SEQRES   5 D  462  SER ALA GLY THR GLY ASN THR LYS TYR SER GLN LYS PHE          
SEQRES   6 D  462  ARG GLY ARG VAL THR PHE THR ARG ASP THR SER ALA THR          
SEQRES   7 D  462  THR ALA TYR MET GLY LEU SER SER LEU ARG PRO GLU ASP          
SEQRES   8 D  462  THR ALA VAL TYR TYR CYS ALA ARG ASP PRO TYR GLY GLY          
SEQRES   9 D  462  GLY LYS SER GLU PHE ASP TYR TRP GLY GLN GLY THR LEU          
SEQRES  10 D  462  VAL THR VAL SER SER ALA SER PRO THR SER PRO LYS VAL          
SEQRES  11 D  462  PHE PRO LEU SER LEU ASP SER THR PRO GLN ASP GLY ASN          
SEQRES  12 D  462  VAL VAL VAL ALA CYS LEU VAL GLN GLY PHE PHE PRO GLN          
SEQRES  13 D  462  GLU PRO LEU SER VAL THR TRP SER GLU SER GLY GLN ASN          
SEQRES  14 D  462  VAL THR ALA ARG ASN PHE PRO PRO SER GLN ASP ALA SER          
SEQRES  15 D  462  GLY ASP LEU TYR THR THR SER SER GLN LEU THR LEU PRO          
SEQRES  16 D  462  ALA THR GLN CYS PRO ASP GLY LYS SER VAL THR CYS HIS          
SEQRES  17 D  462  VAL LYS HIS TYR THR ASN PRO SER GLN ASP VAL THR VAL          
SEQRES  18 D  462  PRO CYS PRO VAL PRO PRO PRO PRO PRO CYS CYS HIS PRO          
SEQRES  19 D  462  ARG LEU SER LEU HIS ARG PRO ALA LEU GLU ASP LEU LEU          
SEQRES  20 D  462  LEU GLY SER GLU ALA ASN LEU THR CYS THR LEU THR GLY          
SEQRES  21 D  462  LEU ARG ASP ALA SER GLY ALA THR PHE THR TRP THR PRO          
SEQRES  22 D  462  SER SER GLY LYS SER ALA VAL GLN GLY PRO PRO GLU ARG          
SEQRES  23 D  462  ASP LEU CYS GLY CYS TYR SER VAL SER SER VAL LEU PRO          
SEQRES  24 D  462  GLY CYS ALA GLN PRO TRP ASN HIS GLY GLU THR PHE THR          
SEQRES  25 D  462  CYS THR ALA ALA HIS PRO GLU LEU LYS THR PRO LEU THR          
SEQRES  26 D  462  ALA ASN ILE THR LYS SER GLY ASN THR PHE ARG PRO GLU          
SEQRES  27 D  462  VAL HIS LEU LEU PRO PRO PRO SER GLU GLU LEU ALA LEU          
SEQRES  28 D  462  ASN GLU LEU VAL THR LEU THR CYS LEU ALA ARG GLY PHE          
SEQRES  29 D  462  SER PRO LYS ASP VAL LEU VAL ARG TRP LEU GLN GLY SER          
SEQRES  30 D  462  GLN GLU LEU PRO ARG GLU LYS TYR LEU THR TRP ALA SER          
SEQRES  31 D  462  ARG GLN GLU PRO SER GLN GLY THR THR THR PHE ALA VAL          
SEQRES  32 D  462  THR SER ILE LEU ARG VAL ALA ALA GLU ASP TRP LYS LYS          
SEQRES  33 D  462  GLY ASP THR PHE SER CYS MET VAL GLY HIS GLU ALA LEU          
SEQRES  34 D  462  PRO LEU ALA PHE THR GLN LYS THR ILE ASP ARG LEU ALA          
SEQRES  35 D  462  GLY LYS PRO THR HIS VAL ASN VAL SER VAL VAL MET ALA          
SEQRES  36 D  462  GLU VAL ASP GLY THR CYS TYR                                  
CRYST1    1.000    1.000    1.000  90.00  90.00  90.00 P 1           1          
ORIGX1      1.000000  0.000000  0.000000        0.00000                         
ORIGX2      0.000000  1.000000  0.000000        0.00000                         
ORIGX3      0.000000  0.000000  1.000000        0.00000                         
SCALE1      1.000000  0.000000  0.000000        0.00000                         
SCALE2      0.000000  1.000000  0.000000        0.00000                         
SCALE3      0.000000  0.000000  1.000000        0.00000                         
